Author

Kate L Li

Institutions: University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center

Observed institutions: University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center, Actinium Pharmaceuticals (United States)

OpenAlex ID: A5111084478

High-Dose Targeted Radiation with 131I-Apamistamab Prior to HCT Demonstrated a Dose-Response for Durable Complete Remission in Patients with R/R AML

2023 · Mark R. Litzow, George Chen, et al. · Blood · 2

Dose-Response Demonstrated for Durable Complete Remission Following High-Dose Targeted Radiation with 131I-Apamistamab Prior to HCT in Patients with R/R AML

2024 · George L Chen, Camille Abboud, et al. · Transplantation and Cellular Therapy · 1

Works count: 2

Citation count: 3

H-index: 1

I10-index: